Well, this one was wrong right out of the gate. Eight days ago we put on an out of the money put spread in IBB, the biotech etf. The thought was that if the small …
Continue readingREGN
The Biotech sector has been a massive out-performer over the last year, with the IBB (iShares Nasdaq Biotech etf) up 13% in 2015, and up 65% since from the 52 week lows made in April of last …
Continue readingThe Biotech ETF, IBB, is up more than 50% in 2013, quite a performance for a relatively well distributed ETF with no one component comprising more than 9% of the ETF’s weight. The rally in …
Continue reading